Early clinical trials show significant weight reduction, often greater than that seen with single-pathway GLP-1 agonists. Because it acts on three receptors, GLP-3 is being studied for individuals with obesity or weight-related conditions.

Type 2 Diabetes & Metabolic Dysfunction: Due to its multi-pathway action, retatrutide is being evaluated for its ability to: improve insulin sensitivity, enhance glycemic control, reduce fasting and post-meal glucose levels.

Cardiometabolic Health Indicators: Studies suggest potential benefits in markers associated with cardiometabolic risk, such as: improved lipid profiles, reduced inflammatory markers, decreased liver fat (being studied for fatty liver/metabolic liver disease). Trials also show reductions in total body fat, preservation of lean mass, partly due to increased energy expenditure.

Due to the nature of research peptides and chemicals, all sales are final.

However, we offer replacement options in limited cases. Please refer to our Refund Policy for more information.

Processing time: 1–3 business days.
During high-volume periods, processing may take longer.

Orders are processed Monday – Friday, excluding Federal holidays.

Standard Priority Mail via United States Postal Service (USPS) $13.00 per order

We do not offer expedited or international shipping at this time. For more information, please visit our Shipping Policy.

Ingredients: GLP3 30mg & 60mg dosages

Type: Triple peptide formulation

Form: Lyophilized powder 

Purity: ≥99% (HPLC)

Storage: Store at 2–8 °C, protected from light and moisture

For research purposes only.